limited cutaneous scleroderma
GPTKB entity
Statements (34)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
autoimmune disease
connective tissue disease |
| gptkbp:affects |
gptkb:skin
lungs gastrointestinal tract esophagus blood vessels |
| gptkbp:alsoKnownAs |
CREST syndrome
lcSSc |
| gptkbp:associatedWith |
anticentromere antibodies
|
| gptkbp:characterizedBy |
gptkb:Raynaud's_phenomenon
telangiectasia calcinosis esophageal dysmotility sclerodactyly skin thickening of hands, face, and forearms |
| gptkbp:complication |
gptkb:gastroesophageal_reflux_disease
pulmonary arterial hypertension digital ulcers |
| gptkbp:diagnosedBy |
clinical examination
autoantibody testing |
| gptkbp:differentialDiagnosis |
gptkb:diffuse_cutaneous_scleroderma
|
| gptkbp:firstDescribed |
20th century
|
| https://www.w3.org/2000/01/rdf-schema#label |
limited cutaneous scleroderma
|
| gptkbp:ICD-10_code |
M34.0
|
| gptkbp:onset |
adulthood
|
| gptkbp:parent |
gptkb:systemic_sclerosis
|
| gptkbp:prevalence |
rare disease
more common in women |
| gptkbp:treatment |
gptkb:proton_pump_inhibitors
immunosuppressive drugs vasodilators |
| gptkbp:bfsParent |
gptkb:Scleroderma
|
| gptkbp:bfsLayer |
7
|